Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Danimer Scientific Inc (NYSE: DNMR) closed at $0.81 in the last session, up 5.01% from day before closing price of $0.77. In other words, the price has increased by $5.01 from its previous closing price. On the day, 1.17 million shares were traded. DNMR stock price reached its highest trading level at $0.8496 during the session, while it also had its lowest trading level at $0.7607.
Ratios:
We take a closer look at DNMR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.26 and its Current Ratio is at 6.87. In the meantime, Its Debt-to-Equity ratio is 1.47 whereas as Long-Term Debt/Eq ratio is at 1.45.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on April 09, 2024, Downgraded its rating to Neutral and sets its target price to $1.25 from $3.50 previously.
On October 12, 2022, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $4.50.
On September 23, 2021, Cowen started tracking the stock assigning a Outperform rating and target price of $21.Cowen initiated its Outperform rating on September 23, 2021, with a $21 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 28 ’23 when HENDRIX RICHARD J bought 50,000 shares for $0.94 per share. The transaction valued at 46,915 led to the insider holds 50,000 shares of the business.
HENDRIX RICHARD J bought 50,000 shares of DNMR for $46,480 on Nov 28 ’23. The Director now owns 391,324 shares after completing the transaction at $0.93 per share. On Jun 20 ’23, another insider, Tuten Scott, who serves as the Chief Marketing Officer of the company, sold 10,000 shares for $2.74 each. As a result, the insider received 27,390 and left with 346,478 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNMR now has a Market Capitalization of 91975432 and an Enterprise Value of 440873376. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.97 while its Price-to-Book (P/B) ratio in mrq is 0.30. Its current Enterprise Value per Revenue stands at 9.444 whereas that against EBITDA is -4.602.
Stock Price History:
The Beta on a monthly basis for DNMR is 1.61, which has changed by -0.76966965 over the last 52 weeks, in comparison to a change of 0.22379243 over the same period for the S&P500. Over the past 52 weeks, DNMR has reached a high of $3.56, while it has fallen to a 52-week low of $0.60. The 50-Day Moving Average of the stock is -27.39%, while the 200-Day Moving Average is calculated to be -43.24%.
Shares Statistics:
According to the various share statistics, DNMR traded on average about 926.10K shares per day over the past 3-months and 746220 shares per day over the past 10 days. A total of 102.83M shares are outstanding, with a floating share count of 101.72M. Insiders hold about 10.96% of the company’s shares, while institutions hold 30.57% stake in the company. Shares short for DNMR as of 1713139200 were 22000680 with a Short Ratio of 23.76, compared to 1710460800 on 21295660. Therefore, it implies a Short% of Shares Outstanding of 22000680 and a Short% of Float of 21.39.
Earnings Estimates
Current recommendations for the stock of the company come from 3.0 analysts. On average, analysts expect EPS of -$0.26 for the current quarter, with a high estimate of -$0.23 and a low estimate of -$0.3, while EPS last year was -$0.36. The consensus estimate for the next quarter is -$0.23, with high estimates of -$0.19 and low estimates of -$0.27.
Analysts are recommending an EPS of between -$0.76 and -$1.07 for the fiscal current year, implying an average EPS of -$0.87. EPS for the following year is -$0.61, with 4.0 analysts recommending between -$0.3 and -$0.9.
Revenue Estimates
According to 3 analysts, the current quarter’s revenue is expected to be $11.06M. It ranges from a high estimate of $12.1M to a low estimate of $9.59M. As of the current estimate, Danimer Scientific Inc’s year-ago sales were $11.93MFor the next quarter, 3 analysts are estimating revenue of $12.88M. There is a high estimate of $13.1M for the next quarter, whereas the lowest estimate is $12.55M.
A total of 5 analysts have provided revenue estimates for DNMR’s current fiscal year. The highest revenue estimate was $110M, while the lowest revenue estimate was $62.4M, resulting in an average revenue estimate of $80.09M. In the same quarter a year ago, actual revenue was $46.68MBased on 5 analysts’ estimates, the company’s revenue will be $142.14M in the next fiscal year. The high estimate is $156.7M and the low estimate is $119M.
